Skip to content

Assistive Device Training in Multiple Sclerosis

Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02408718
Acronym
ADT
Enrollment
40
Registered
2015-04-03
Start date
2015-07-31
Completion date
2016-09-30
Last updated
2016-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Mobility, walking aids, falls, gait and balance

Brief summary

The purpose of this study is to determine whether a training program in the use of ambulatory assistive devices (such as canes, walkers, etc) can reduce falls and increase functional mobility and neural connectivity in people with Multiple Sclerosis.

Detailed description

40 people with Multiple Sclerosis, who routinely use ambulatory assistive devices and have fallen at least once in the past year, will be randomized into two groups. One group will receive a 6-week training program in the use of their assistive device; the other group will be wait-listed, and may choose to receive the training after their participation in the study is completed. All participants will receive mobility assessments at baseline, 6-8 weeks later, and 3 months after that. All participants will record their falls on falls calendars. Participants in the training group will receive MRI scans to assess neural connectivity at baseline and after completion of the training program. The purpose of the study is to determine whether participation in the training program reduces falls and increases functional mobility when compared to the wait-listed group, and also to determine whether any change in neural connectivity, as assessed by MRI scans, is seen in those who participate in the training.

Interventions

BEHAVIORALAssistive Device Training

Six-week training program on the proper use of the subject's assistive device (eg. cane, walker, etc).

Sponsors

Oregon Health and Science University
CollaboratorOTHER
Portland VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Multiple Sclerosis of any type, * self-reported history of at least 1 fall in the previous year, * able to walk at least 25 feet with or without an assistive device, * clinically stable Multiple Sclerosis (no relapse in 30 days prior to enrollment), * intermittent or constant unilateral or bilateral assistance required to walk, * right-handed, willingness to remain consistent with medication use and level of physical activity for the duration of the study.

Exclusion criteria

* serious psychiatric or medical conditions that would preclude reliable participation in the study, * dementia (MMSE \<24), * deafness, * blindness, * inability to follow directions in English, * significant upper extremity tremor or weakness, * more than 1 hour of assistive device training within the previous 3 years, * any exclusions to receiving MRI scans (implanted devices, anxiety, claustrophobia, body weight over 350 lbs).

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Functional Mobility at Completion of Training and the Following Three MonthsAt baseline, 1 week after completion of training, 3 months laterTimed Up and Go test, Timed 25-Foot Walk, 2 minute timed walk), Multiple Sclerosis Walking Scale-12
Change from Baseline in Falls at Completion of Training and the Following Three MonthsFirst week of training, last week of training, 3 months laterChange in rate of falls between time frames
Change from Baseline in Functional Neural Connectivity (fMRI) at Completion of TrainingAt baseline, 1 week after completion of trainingResting-state (task free) functional Magnetic Resonance Imaging (fcMRI)

Secondary

MeasureTime frameDescription
Change from Baseline in Multiple Sclerosis Impact at Completion of Training and the Following Three MonthsAt baseline, 1 week after completion of training, 3 months laterMultiple Sclerosis Impact Scale-29
Change from Baseline in Physical Activity at Completion of Training and the Following Three MonthsAt baseline, 1 week after completion of training, 3 months laterInternational Physical Activity Questionnaire
Change from Baseline in Satisfaction with Assistive Device at Completion of Training and the Following Three MonthsAt baseline, 1 week after completion of training, 3 months laterQuebec User Evaluation of Satisfaction with Assistive Technologies
Change from Baseline in Balance Confidence at Completion of Training and the Following Three MonthsAt baseline, 1 week after completion of training, 3 months laterActivities-specific Balance Confidence Questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026